The dividend cheque was presented to Shri J.P. Nadda, Union Minister of Health & Family Welfare, by Dr. Anitha Thampi, Chairperson of HLL, in the presence of Smt. Anupriya Patel, Minister of State for Health & Family Welfare, Smt. Punya Salila Srivastava, Union Health Secretary, Shri Hovyeda Abbas, AS&FA, and Shri Vijay Nehra, Joint Secretary, Ministry of Health & Family Welfare. Senior officials from HLL, including Directors of Marketing and Finance, were also present.
HLL’s Impact on Accessible and Affordable Healthcare
Speaking at the event, Shri J.P. Nadda praised HLL as a reliable contributor to India’s medical services sector. He highlighted the company’s role in promoting accessible, affordable, and quality healthcare through its initiatives, including AMRIT Pharmacies. Over the past decade, AMRIT Pharmacies have served more than 6.7 crore people, saving over ₹8,000 crore in out-of-pocket expenses.
The Minister noted that HLL, along with its subsidiaries, has emerged as a key player in transforming the health sector by providing essential medicines and surgical products at affordable prices.
Financial Growth and Performance
During FY 2024–25, HLL recorded revenue from operations of ₹4,500 crore, marking a 20% growth compared to the previous year. Its net worth rose to ₹1,100 crore as of March 31, 2025. On a consolidated basis, including subsidiaries HITES, GAPL, and Lifespring Hospitals, the HLL Group achieved a total revenue of ₹4,900 crore, reflecting a 19% increase year-on-year.
Legacy and Vision
Founded on 1st March 1966, HLL Lifecare Limited has transitioned from addressing India’s population control challenges to becoming a multi-product, multi-service healthcare enterprise. With its 60th anniversary approaching, HLL continues to strengthen India’s healthcare landscape, ensuring equitable access, affordability, and quality through strategic initiatives and innovative services.